Loses hair may cure? Recently discovered PGD2 (prostaglandin D2) brings the hope which the conclusion lost hair

Researchers from the University of Pennsylvania recently announced that it may soon have winged bald men and women.

Where is the breakthrough in the treatment of hair loss?

Scientists at the University announced that they have identified an unusually high concentration of lipids (fatty acids) known as the non-bald scalp hair bearing areas of the prostaglandin D2 (PGD2) compound. Further investigation, they determined that the emergence of PGD2, and inhibit hair growth, the GPR44 receptor binding.

Scientific research

To further prove this point, the researchers examined the scalp of bald men between 2240 and 65 years of age, found that PGD2 level was about three times higher, on the bare scalp tissue. In addition, they can induce mouse prostaglandin D2 and G protein-coupled receptor (GPR44) the introduction of baldness.

Complication

Although exciting, this discovery reveals the complicated hair loss process, involving more than one property is only one more step. This includes the key role of the male androgen dihydrotestosterone or DHT. If you stop GPR44 receptor will regenerate hair bald men, or if it only prevents baldness has not been the impact of androgenetic alopecia (thinning hair genetic) In addition, it is not yet clear. The impact of the female bald PGD2 has not been fully understood at this time.

Potential future hair loss treatment

The will GPR44 receptor antagonist treatment of asthma drugs in development, is currently in the final stages of FDA testing. Therefore, the new hair loss treatment can slow, stop or even reverse the impact of hereditary baldness may be right on the horizon. But taking into account the drug must undergo extensive testing for a specific purpose, genetic baldness a possible new treatment may still be brewing for several years.

Therefore, the bald man should not give up their current treatment options, but not yet adhere to the proven hair loss drugs, the real work. This includes the FDA approved the treatment of insurance (non-finasteride), oral DHT blockers (anti-androgen) men only printed (minoxidil), for external use to stimulate hair growth for men and women ended.

The men and women with extensive hair loss may also need to research and consulting with leading hair restoration of their choice, including the doctor may consider a hair transplant. Hair transplants, but not for everyone, men and women do their own due diligence is strongly recommended to consider this option, the course of the study, doctors and interests, limitations and potential risks, to go along with it.